top of page


Lilly expands Gate Bioscience collaboration for molecular-gate protein degraders
Eli Lilly and Gate Bioscience have expanded their drug-discovery collaboration by adding a new target and an option for a second under Gate's Molecular Gate platform.

nuaxia
Oct 72 min read


Ascendis and BioMarin agree global Yuviwel patent settlement and licence
The binding term sheet resolves litigation between Ascendis Pharma and BioMarin while granting Ascendis a worldwide licence covering YUVIWEL and other navepegritide-related products.

nuaxia
Sep 12 min read
bottom of page